Bayer’s stock rose sharply after the U.S. Supreme Court ruled in favor of the company in a case involving its Roundup weedkiller. The decision removes a major legal threat that has weighed on the stock for years.
The high court ruled that states cannot impose labeling warning requirements that differ from federal standards. This decision effectively blocks claims that Bayer failed to warn consumers about potential risks associated with Roundup.
Shares jumped more than 10% in early trading following the announcement. Investors viewed the ruling as a significant win for Bayer, which has faced thousands of lawsuits over the product.
The case centered on whether federal law preempts state-level labeling rules for agricultural chemicals. The Supreme Court’s decision clarifies that federal authority over such warnings is supreme.
Bayer acquired Roundup through its purchase of Monsanto in 2018. Since then, the company has faced extensive litigation, with plaintiffs alleging the weedkiller causes cancer.
The ruling may reduce Bayer’s legal liabilities and lower future settlement costs. The company has previously set aside billions of dollars to resolve claims.
Legal analysts note the decision could influence similar cases pending in lower courts. The outcome provides Bayer with greater certainty in ongoing disputes.
Bayer continues to defend Roundup’s safety, citing regulatory approvals worldwide. The company plans to keep the product on the market.
